Skip to main content

Want a detailed portfolio tracker?

InflaRx N.V. (IFRX) P/E (2017 - 2026)

InflaRx N.V. (IFRX) P/E from Nov 7, 2017 to Jul 20, 2026. The TTM InflaRx N.V. (IFRX) P/E is -2.57. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of InflaRx N.V. (IFRX)

YearP/EChange
2026-2.57+93.25%
2025-1.33-54.24%
2024-2.91+34.87%
2023-2.16-37.09%
2022-3.43-2.52%
2021-3.52+3.66%
2020-3.40+95.69%
2019-1.73-93.29%
2018-25.85-1.36%
2017-26.21N/A

Comparison InflaRx N.V. (IFRX) P/E with competitors

InflaRx N.V. (IFRX) P/E is -2.57.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.07%
NBYStablecoin Development Corp0.00-100.17%
ENLVEnlivex Ltd0.07-102.91%
FGENFibroGen Inc0.24-109.33%
CHRSCoherus Biosciences Inc0.85-132.97%
FBIOFortress Biotech Inc0.95-136.87%
ORMPOramed Pharmaceuticals Inc1.50-158.39%
AGENAgenus Inc3.01-216.92%
INVAInnoviva Inc3.15-222.53%
VXRTVaxart Inc3.55-237.91%
CRMDCorMedix Inc3.63-240.97%
CVACCureVac N.V.4.45-272.72%
GLPGGalapagos NV4.86-288.77%
SRPTSarepta Therapeutics Inc4.88-289.67%
ABEOAbeona Therapeutics Inc5.39-309.31%
ABUSArbutus Biopharma Corp5.60-317.39%
ZVRAZevra Therapeutics Inc5.89-328.72%
SPROSpero Therapeutics Inc6.23-341.98%
CGENCompugen Ltd6.31-345.30%
RIGLRigel Pharmaceuticals6.87-366.98%
SLXNSilexion Therapeutics Corp7.30-383.46%
OMEROmeros Corporation9.26-459.71%
AUPHAurinia Pharmaceuticals Inc9.58-472.38%
PLXProtalix BioTherapeutics Inc10.89-523.12%
ACADAcadia Pharmaceuticals Inc11.73-555.66%
TBPHTheravance Biopharma Inc12.26-576.39%
ADMAAdma Biologics Inc12.42-582.45%
HRMYHarmony Biosciences Holdings Inc13.82-636.92%
SABSSAB Biotherapeutics Inc14.14-649.20%
NAGENiagen Bioscience Inc14.82-675.69%
INCYIncyte Corp15.82-714.71%
REGNRegeneron Pharmaceuticals Inc15.86-716.04%
PBYIPuma Biotechnology Inc17.32-772.72%
CPRXCatalyst Pharmaceuticals Inc17.44-777.53%
EXELExelixis Inc17.54-781.36%
TGTXTG Therapeutics Inc18.97-836.84%
MDXGMimedx Group Inc20.55-898.48%
XOMAXOMA Royalty Corp22.87-988.72%
ARGXArgen X SE24.30-1044.01%
CTMXCytomX Therapeutics Inc24.82-1064.34%
XOMAOXOMA Royalty Corp25.34-1084.68%
HALOHalozyme Therapeutics Inc25.62-1095.52%
XOMAPXOMA Royalty Corp25.67-1097.32%
VRTXVertex Pharmaceuticals Inc27.99-1187.64%
RPRXRoyalty Pharma plc - Class A28.69-1214.55%
SLNOSoleno Therapeutics Inc29.02-1227.29%
ASNDAscendis Pharma A/S30.09-1268.87%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1572.94%
APLSApellis Pharmaceuticals Inc39.02-1616.03%
BMRNBiomarin Pharmaceutical Inc42.21-1740.00%
KRYSKrystal Biotech Inc45.34-1861.66%
ONCBeiGene Ltd69.54-2801.75%
PHARPharming Group N.V.75.03-3014.86%
TECHBio-Techne Corp101.96-4061.24%
VCELVericel Corp109.92-4370.62%
ALNYAlnylam Pharmaceuticals Inc117.96-4683.13%
GMABGenmab140.29-5550.52%
TLXTelix Pharmaceuticals Ltd162.15-6399.89%
CORTCorcept Therapeutics Inc212.86-8369.85%